3D Biomatrix recently received a key patent for its research technology, a milestone that is setting the company up for more growth in 2015.
The patent is for the company's hangar system, which scientists use for life sciences research. The patent helps the company validate the uniqueness of its products and prevents knock offs from competitors.
"It's an important patent for us because it covers our core technology," says Laura Schrader, president & CEO of
3D Biomatrix.
The University of Michigan spin-out, it calls the Venture Accelerator home, makes 3D cell culture hanging drop plates for lab research in cancer treatments or stem cells. The plates allow cells to grow in 3 dimensions like they do in the body. Most current methods offer only flat surfaces.
The 96-well plates sell well for users using manual lab methods. The 384-well plates are growing in use as they work well with automated lab equipment. The company also makes transfer tools and assay kits.
Schrader says sales for 3D Biomatrix were up in 2014 but declined to say how much. It currently has 30 distributors and is looking to expand into new markets this year.
Source: Laura Schrader, president & CEO of 3D Biomatrix
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.